The Federal Antimonopoly Service of Russia (FAS) has approved a new methodology for setting maximum wholesale and retail markups on drugs listed in the Essential Medicines List (ЖНВЛП). The updated rules replace FAS Order No. 820/20 from September 9, 2020, and give regional authorities more flexibility in managing medicine prices.
Valery Afanasyev, Partner, GR & Risk at Baikal Lobridge, explains:
Valery Afanasyev, Partner, GR & Risk at Baikal Lobridge, explains:
"First, outdated terms have been updated. Second, regions will now be able to split the pricing category for medicines "over 500 rubles" into several subgroups, to better control the cost of expensive medicines. Third, pharmacies and distributors can now submit price information to regional authorities electronically — something that wasn’t possible before."
In addition, the new system allows regions to adjust markups based on location, which is especially useful for remote areas.
Read more in the Pharmaceutical Bulletin.
Read more in the Pharmaceutical Bulletin.
